These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25823465)

  • 21. Galectin-3 is associated with a poor prognosis in primary hepatocellular carcinoma.
    Jiang SS; Weng DS; Wang QJ; Pan K; Zhang YJ; Li YQ; Li JJ; Zhao JJ; He J; Lv L; Pan QZ; Xia JC
    J Transl Med; 2014 Sep; 12():273. PubMed ID: 25260879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3.
    Lu Y; Yue X; Cui Y; Zhang J; Wang K
    Biochem Biophys Res Commun; 2013 Nov; 441(4):873-9. PubMed ID: 24211205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-342-3p affects hepatocellular carcinoma cell proliferation via regulating NF-κB pathway.
    Zhao L; Zhang Y
    Biochem Biophys Res Commun; 2015 Feb; 457(3):370-7. PubMed ID: 25580008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.
    Shih TC; Tien YJ; Wen CJ; Yeh TS; Yu MC; Huang CH; Lee YS; Yen TC; Hsieh SY
    J Hepatol; 2012 Sep; 57(3):584-91. PubMed ID: 22613005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
    Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
    Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma.
    Law PT; Ching AK; Chan AW; Wong QW; Wong CK; To KF; Wong N
    Carcinogenesis; 2012 Jun; 33(6):1134-41. PubMed ID: 22431718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of microRNA-224 in cell proliferation, migration, invasion, and anti-apoptosis in hepatocellular carcinoma.
    Zhang Y; Takahashi S; Tasaka A; Yoshima T; Ochi H; Chayama K
    J Gastroenterol Hepatol; 2013 Mar; 28(3):565-75. PubMed ID: 22989374
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma.
    Shen G; Rong X; Zhao J; Yang X; Li H; Jiang H; Zhou Q; Ji T; Huang S; Zhang J; Jia H
    Carcinogenesis; 2014 Dec; 35(12):2748-55. PubMed ID: 25280563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-451 inhibits cell proliferation in human hepatocellular carcinoma through direct suppression of IKK-β.
    Li HP; Zeng XC; Zhang B; Long JT; Zhou B; Tan GS; Zeng WX; Chen W; Yang JY
    Carcinogenesis; 2013 Nov; 34(11):2443-51. PubMed ID: 23740840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioinformatics analysis identifies miR-221 as a core regulator in hepatocellular carcinoma and its silencing suppresses tumor properties.
    He XX; Guo AY; Xu CR; Chang Y; Xiang GY; Gong J; Dan ZL; Tian DA; Liao JZ; Lin JS
    Oncol Rep; 2014 Sep; 32(3):1200-10. PubMed ID: 24993451
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity.
    Su H; Yang JR; Xu T; Huang J; Xu L; Yuan Y; Zhuang SM
    Cancer Res; 2009 Feb; 69(3):1135-42. PubMed ID: 19155302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isatis indigotica induces hepatocellular cancer cell death via caspase-independent apoptosis-inducing factor translocation apoptotic pathway in vitro and in vivo.
    Chung YC; Tang FY; Liao JW; Chung CH; Jong TT; Chen SS; Tsai CH; Chiang EP
    Integr Cancer Ther; 2011 Jun; 10(2):201-14. PubMed ID: 21382959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-206, down-regulated in hepatocellular carcinoma, suppresses cell proliferation and promotes apoptosis.
    Yunqiao L; Vanke H; Jun X; Tangmeng G
    Hepatogastroenterology; 2014; 61(133):1302-7. PubMed ID: 25436301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin inhibits hepatocellular carcinoma cell proliferation in vitro and in vivo via inducing cell cycle arrest and apoptosis.
    Shi T; Fujita K; Gong J; Nakahara M; Iwama H; Liu S; Yoneyama H; Morishita A; Nomura T; Tani J; Takuma K; Tadokoro T; Himoto T; Oura K; Tsutsui K; Kobara H; Masaki T
    Oncol Rep; 2020 Aug; 44(2):457-468. PubMed ID: 32627038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-124 suppresses cell proliferation in hepatocellular carcinoma by targeting PIK3CA.
    Lang Q; Ling C
    Biochem Biophys Res Commun; 2012 Sep; 426(2):247-52. PubMed ID: 22940133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic antitumoral activity and induction of apoptosis by novel pan Bcl-2 proteins inhibitor apogossypolone with adriamycin in human hepatocellular carcinoma.
    Mi JX; Wang GF; Wang HB; Sun XQ; Ni XY; Zhang XW; Tang JM; Yang DJ
    Acta Pharmacol Sin; 2008 Dec; 29(12):1467-77. PubMed ID: 19026166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-502 inhibits cell proliferation and tumor growth in hepatocellular carcinoma through suppressing phosphoinositide 3-kinase catalytic subunit gamma.
    Chen S; Li F; Chai H; Tao X; Wang H; Ji A
    Biochem Biophys Res Commun; 2015 Aug; 464(2):500-5. PubMed ID: 26163264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway.
    Liu FY; Zhou SJ; Deng YL; Zhang ZY; Zhang EL; Wu ZB; Huang ZY; Chen XP
    Cell Death Dis; 2015 Mar; 6(3):e1670. PubMed ID: 25741595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
    Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
    Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rapamycin and CCI-779 inhibit the mammalian target of rapamycin signalling in hepatocellular carcinoma.
    Hui IC; Tung EK; Sze KM; Ching YP; Ng IO
    Liver Int; 2010 Jan; 30(1):65-75. PubMed ID: 19845851
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.